MPO Imaging Probes for Specific Detection Across Tissue Barriers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing imaging agents for myeloperoxidase (MPO) suffer from inadequate tissue penetration and lack of specificity, limiting their use in research and translational studies, particularly in detecting early inflammatory events and neurological inflammation where crossing the blood-brain barrier is essential.
Innovation Solution
Development of novel positron emission tomography (PET) and fluorescent imaging probes targeting MPO, such as compounds of Formula I and Formula VI, which accumulate at MPO sites for imaging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing imaging agents are used for MPO detection, then imaging can be performed, but tissue penetration is inadequate and specificity is lacking
Solution Approach 1:
The patent modifies molecular parameters of imaging agents including hydrophobicity, molecular weight, and functional group composition to optimize both tissue penetration and MPO specificity. Compound structures are systematically varied with different R groups and linkers to achieve optimal balance between penetration capability and binding specificity.
Solution Approach 2:
The imaging agents are designed as composite molecules combining MPO-specific binding moieties with imaging functional groups (PET or fluorescent). The compounds integrate multiple functional elements including aromatic rings, heterocyclic groups, and specific linkers to achieve both deep tissue penetration and high specificity for MPO detection.
2Measurement precision
If imaging agents are designed for high specificity, then MPO detection accuracy improves, but tissue penetration capability deteriorates
Solution Approach 1:
The imaging agents exhibit local quality optimization where specific regions of the molecule (aromatic rings, heterocyclic groups) provide MPO binding specificity while other regions (linker length, hydrophobic groups) control tissue penetration. This spatial differentiation of functional properties within the single molecule resolves the contradiction between specificity and penetration.
Solution Approach 2:
The molecular structures are designed with dynamic flexibility through variable linker regions that can adapt to different tissue environments. The compounds can adjust their conformation and interaction properties based on local conditions, enabling both deep penetration and high-specificity binding.
3Productivity
If conventional imaging probes are used, then general imaging is possible, but detection of early inflammatory events and neurological inflammation is limited
Solution Approach 1:
The patent systematically varies molecular parameters including hydrophobicity, molecular weight, and functional group composition to optimize blood-brain barrier penetration. Specific compound structures with controlled lipophilicity and molecular size enable neurological inflammation detection while maintaining early inflammatory event detection capability.
Solution Approach 2:
The imaging agents are designed as multi-functional compounds that can detect MPO in diverse tissue types including brain, liver, and inflamed tissues. The compounds serve multiple purposes: early inflammation detection, neurological inflammation imaging, and quantification of MPO activity across different disease models.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These probes provide sensitive and specific imaging of MPO activity, enabling effective detection of inflammatory diseases and disorders associated with abnormal MPO activity, including cancers, rheumatic diseases, infectious diseases, cardiovascular disorders, autoimmune disorders, and neurological conditions.
Implementation Method 1
Myeloperoxidase (MPO) is a heme-containing oxidizing enzyme mainly produced by neutrophil granulocytes and monocytes and plays a crucial role in host defense against pathogen by generating reactive oxygen species (ROS) and other oxidants
Data Source
AI summary
Provided herein are compounds useful as imaging agents. Exemplary compounds provided herein are useful as myeloperoxidase imaging agents using positron emission tomography or fluorescence imaging techniques. Methods for preparing the compounds provided herein and diagnostic methods using radiolabeled arid unlabeled compounds are also provided.